SAN ANTONIO--(BUSINESS WIRE)--Nov 14, 2024--. bioAffinity Technologies, Inc.(Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for ...
News
- bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024 | News | bakersfield.com
- bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024 - Business Wire
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, ...
- PDS Biotechnology: Q3 Earnings Snapshot - San Antonio Express-News
EAST PRINCETON, N.J. (AP) — EAST PRINCETON, N.J. (AP) — PDS Biotechnology Corporation ... The San Antonio Spurs announced coach Gregg Popovich suffered ...
- Small fossil has big implications for bird brain evolution | TPR - Texas Public Radio
Bioscience-Medicine · Border & Immigration · Economy & Labor · Criminal ... KSTX 89.1 FM - San Antonio · KPAC 88.3 FM - San Antonio · KTXI 90.1 FM ...
- SEC Form 10-Q filed by Structure Therapeutics Inc. - Quantisnow
... San Antonio, TX. Title: Novel Oral Small Molecule Dual Amylin and ... Biotechnology: Biological Products (No Diagnostic Substances).